Advertisement

Heart and Vessels

, Volume 34, Issue 2, pp 199–207 | Cite as

Eleven-year temporal trends of clinical characteristics and long-term outcomes in patients undergoing percutaneous coronary intervention for acute coronary syndrome in the Shinken database

  • Yoshimi NumaoEmail author
  • Shinya Suzuki
  • Hiroto Kano
  • Junji Yajima
  • Yuji Oikawa
  • Shunsuke Matsuno
  • Takuto Arita
  • Naoharu Yagi
  • Hiroaki Semba
  • Yuko Kato
  • Takayuki Otsuka
  • Tokuhisa Uejima
  • Takeshi Yamashita
Original Article

Abstract

Despite the increasing incidence of acute coronary syndrome (ACS) in Japan, its prognosis has improved. However, there is a paucity of longitudinal registry data providing trends of in-hospital care and prognosis of ACS in Japan. ACS patients undergoing percutaneous coronary intervention (PCI) included in the Shinken Database 2004–2014 were divided into two groups according to admission year (2004–2009, n = 390; 2010–2014, n = 328). Patient characteristics, lesion/procedure characteristics, medications at discharge, all-cause mortality, cardiovascular death, acute myocardial infarction (AMI), target lesion revascularization (TLR), re-PCI to new lesion, and coronary artery bypass graft (CABG) within 2 years after discharge were compared between the groups. Prevalence of hypertension, dyslipidemia, and dual antiplatelet/statin prescription increased significantly between periods. Usage of second-generation drug-eluting stents (DES) increased markedly between the two periods (2.6, 66.8%), while those of bare metal stents (64.4, 26.5%) and first-generation DES (25.6, 1.5%) decreased (all, p < 0.01). Two-year event-free survival rate increased for all-cause mortality (94.6–98.3%, p = 0.01), TLR (79.4–96.1%, p < 0.01), and re-PCI to new lesion (87.3–95.1%, p < 0.01). There were no significant differences in cardiovascular death, AMI, or CABG between the two periods. The event-free rates for TLR and re-PCI to new lesion in ACS patients have increased over the last decade in Japan. These observations should be confirmed in larger, longitudinal, multicenter registries.

Keywords

Acute coronary syndrome Percutaneous coronary intervention Time trend 

Notes

Acknowledgements

We thank Shiro Ueda and Nobuko Ueda at Medical Edge Company, Ltd., for assembling the database by the Clinical Study Supporting System and Ineko Hayakawa, Hiroaki Arai, and Hirokazu Aoki for data management and system administration. Dr. Suzuki received research funding and remuneration from Nippon Boehringer Ingelheim. Dr. Yamashita has received research funding and/or lecture fees from Daiichi Sankyo, Bayer Yakuhin, Bristol-Myers Squibb, Pfizer, Nippon Boehringer Ingelheim, Eisai, Mitsubishi Tanabe Pharm, Ono Pharmaceutical, and Toa Eiyo.

Funding

This study was partially supported by the Practical Research Project for Life-Style related Diseases including Cardiovascular Diseases and Diabetes Mellitus from Japan Agency for Medical Research and Development, AMED (15656344).

Compliance with ethical standards

Conflict of interest

Dr. Suzuki and Dr. Takayuki Otsuka received research funding and remuneration from Nippon Boehringer Ingelheim. Dr. Yamashita received research funding from Nippon Boehringer Ingelheim and Daiichi-Sankyo, and remuneration from Nippon Boehringer Ingelheim, Daiichi-Sankyo, Bayer Healthcare, Pfizer, Bristol-Myers Squibb, Eisai, and Ono Pharmaceutical.

References

  1. 1.
    McGovern PG, Jacobs DR Jr, Shahar E, Arnett DK, Folsom AR, Blackburn H, Luepker RV (2001) Trends in acute coronary heart disease mortality, morbidity, and medical care from 1985 through 1997: the Minnesota heart survey. Circulation 104:19–24CrossRefGoogle Scholar
  2. 2.
    Fox CS, Evans JC, Larson MG, Kannel WB, Levy D (2004) Temporal trends in coronary heart disease mortality and sudden cardiac death from 1950 to 1999: the Framingham Heart Study. Circulation 110:522–527CrossRefGoogle Scholar
  3. 3.
    Kitamura A, Sato S, Kiyama M, Imano H, Iso H, Okada T, Ohira T, Tanigawa T, Yamagishi K, Nakamura M, Konishi M, Shimamoto T, Iida M, Komachi Y (2008) Trends in the incidence of coronary heart disease and stroke and their risk factors in Japan, 1964 to 2003: the Akita-Osaka study. J Am Coll Cardiol 52:71–79CrossRefGoogle Scholar
  4. 4.
    Takii T, Yasuda S, Takahashi J, Ito K, Shiba N, Shirato K, Shimokawa H (2010) Trends in acute myocardial infarction incidence and mortality over 30 years in Japan: report from the MIYAGI-AMI Registry Study. Circ J 74:93–100CrossRefGoogle Scholar
  5. 5.
    Yan AT, Tan M, Fitchett D, Chow CM, Fowlis RA, McAvinue TG, Roe MT, Peterson ED, Tu JV, Langer A, Goodman SG (2004) One-year outcome of patients after acute coronary syndromes (from the Canadian Acute Coronary Syndromes Registry). Am J Cardiol 94:25–29CrossRefGoogle Scholar
  6. 6.
    Daida H, Miyauchi K, Ogawa H, Yokoi H, Matsumoto M, Kitakaze M, Kimura T, Matsubara T, Ikari Y, Kimura K, Tsukahara K, Origasa H, Morino Y, Tsutsui H, Kobayashi M, Isshiki T (2013) Management and two-year long-term clinical outcome of acute coronary syndrome in Japan: prevention of atherothrombotic incidents following ischemic coronary attack (PACIFIC) registry. Circ J 77:934–943CrossRefGoogle Scholar
  7. 7.
    Cui Y, Hao K, Takahashi J, Miyata S, Shindo T, Nishimiya K, Kikuchi Y, Tsuburaya R, Matsumoto Y, Ito K, Sakata Y, Shimokawa H (2017) Age-specific trends in the incidence and in-hospital mortality of acute myocardial infarction over 30 years in Japan—report from the Miyagi AMI Registry Study. Circ J 81:520–528CrossRefGoogle Scholar
  8. 8.
    Silber S, Albertsson P, Avilés FF, Camici PG, Colombo A, Hamm C, Jørgensen E, Marco J, Nordrehaug JE, Ruzyllo W, Urban P, Stone GW, Wijns W (2005) Guidelines for percutaneous coronary interventions. The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology. Eur Heart J 26:804–847CrossRefGoogle Scholar
  9. 9.
    FRISC II Investigators (1999) Invasive compared with non-invasive treatment in unstable coronary-artery disease: FRISC II prospective randomised multicentre study. FRagmin and Fast Revascularisation during InStability in Coronary artery disease Investigators. Lancet 354:708–715CrossRefGoogle Scholar
  10. 10.
    Fox KA, Poole-Wilson PA, Henderson RA, Clayton TC, Chamberlain DA, Shaw TR, Wheatley DJ, Pocock SJ (2002) Interventional versus conservative treatment for patients with unstable angina or non-ST-elevation myocardial infarction: the British Heart Foundation RITA 3 randomised trial. Randomized Intervention Trial of unstable Angina. Lancet 360:743–751CrossRefGoogle Scholar
  11. 11.
    Spacek R, Widimský P, Straka Z, Jiresová E, Dvorák J, Polásek R, Karel I, Jirmár R, Lisa L, Budesínský T, Málek F, Stanka P (2002) Value of first day angiography/angioplasty in evolving Non-ST segment elevation myocardial infarction: an open multicenter randomized trial. The VINO Study. Eur Heart J 23:230–238CrossRefGoogle Scholar
  12. 12.
    Suzuki S, Yamashita T, Ohtsuka T, Sagara K, Uejima T, Oikawa Y, Yajima J, Koike A, Nagashima K, Kirigaya H, Ogasawara K, Sawada H, Aizawa T (2008) Prevalence and prognosis of patients with atrial fibrillation in Japan: a prospective cohort of Shinken Database 2004. Circ J 72:914–920CrossRefGoogle Scholar
  13. 13.
    Suzuki S, Yamashita T, Otsuka T, Sagara K, Uejima T, Oikawa Y, Yajima J, Koike A, Nagashima K, Kirigaya H, Ogasawara K, Sawada H, Aizawa T (2011) Recent mortality of Japanese patients with atrial fibrillation in an urban city of Tokyo. J Cardiol 58:116–123CrossRefGoogle Scholar
  14. 14.
    Anderson JL, Adams CD, Antman EM, Bridges CR, Califf RM, Casey DE Jr, Chavey WE 2nd, Fesmire FM, Hochman JS, Levin TN, Lincoff AM, Peterson ED, Theroux P, Wenger NK, Wright RS, Jneid H, Ettinger SM, Ganiats TG, Philippides GJ, Jacobs AK, Halperin JL, Albert NM, Creager MA, DeMets D, Guyton RA, Kushner FG, Ohman EM, Stevenson W, Yancy CW (2013) 2012 ACCF/AHA focused update incorporated into the ACCF/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 61:e179–e347CrossRefGoogle Scholar
  15. 15.
    Murata N, Kaneko H, Yajima J, Oikawa Y, Oshima T, Tanaka S, Kano H, Matsuno S, Suzuki S, Kato Y, Otsuka T, Uejima T, Nagashima K, Kirigaya H, Sagara K, Sawada H, Aizawa T, Yamashita T (2015) The prognostic impact of worsening renal function in Japanese patients undergoing percutaneous coronary intervention with acute coronary syndrome. J Cardiol 66:326–332CrossRefGoogle Scholar
  16. 16.
    Aikawa M, Rabkin E, Okada Y, Voglic SJ, Clinton SK, Brinckerhoff CE, Sukhova GK, Libby P (1998) Lipid lowering by diet reduces matrix metalloproteinase activity and increases collagen content of rabbit atheroma: a potential mechanism of lesion stabilization. Circulation 97:2433–2444CrossRefGoogle Scholar
  17. 17.
    Aikawa M, Sugiyama S, Hill CC, Voglic SJ, Rabkin E, Fukumoto Y, Schoen FJ, Witztum JL, Libby P (2002) Lipid lowering reduces oxidative stress and endothelial cell activation in rabbit atheroma. Circulation 106:1390–1396CrossRefGoogle Scholar
  18. 18.
    Kumai T, Matsumoto N, Koitabashi Y, Takeba Y, Oonuma S, Sekine S, Tadokoro M, Kobayashi S (2005) Pleiotropic effects of 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors: candidate mechanisms for anti-lipid deposition in blood vessels. Curr Med Chem Cardiovasc Hematol Agents 3:195–201CrossRefGoogle Scholar
  19. 19.
    Mills EJ, Rachlis B, Wu P, Devereaux PJ, Arora P, Perri D (2008) Primary prevention of cardiovascular mortality and events with statin treatments: a network meta-analysis involving more than 65,000 patients. J Am Coll Cardiol 52:1769–1781CrossRefGoogle Scholar
  20. 20.
    Allen LA, O’Donnell CJ, Giugliano RP, Camargo CA Jr, Lloyd-Jones DM (2004) Care concordant with guidelines predicts decreased long-term mortality in patients with unstable angina pectoris and non-ST-elevation myocardial infarction. Am J Cardiol 93:1218–1222CrossRefGoogle Scholar
  21. 21.
    Mukherjee D, Fang J, Chetcuti S, Moscucci M, Kline-Rogers E, Eagle KA (2004) Impact of combination evidence-based medical therapy on mortality in patients with acute coronary syndromes. Circulation 109:745–749CrossRefGoogle Scholar
  22. 22.
    Yan AT, Yan RT, Tan M, Huynh T, Soghrati K, Brunner LJ, DeYoung P, Fitchett DH, Langer A, Goodman SG (2007) Optimal medical therapy at discharge in patients with acute coronary syndromes: temporal changes, characteristics, and 1-year outcome. Am Heart J 154:1108–1115CrossRefGoogle Scholar
  23. 23.
    Tuppin P, Neumann A, Danchin N, de Peretti C, Weill A, Ricordeau P, Allemand H (2010) Evidence-based pharmacotherapy after myocardial infarction in France: adherence-associated factors and relationship with 30-month mortality and rehospitalization. Arch Cardiovasc Dis 103:363–375CrossRefGoogle Scholar
  24. 24.
    Bi Y, Gao R, Patel A, Su S, Gao W, Hu D, Huang D, Kong L, Qi W, Wu Y, Yang Y, Turnbull F, CPACS Investigators (2009) Chinese patients with acute coronary syndromes at the time of hospital discharge and 1 year after hospitalization: results from the Clinical Pathways for Acute Coronary Syndromes in China (CPACS) study. Am Heart J 157:509–516CrossRefGoogle Scholar

Copyright information

© Springer Japan KK, part of Springer Nature 2018

Authors and Affiliations

  • Yoshimi Numao
    • 1
    Email author
  • Shinya Suzuki
    • 1
  • Hiroto Kano
    • 1
  • Junji Yajima
    • 1
  • Yuji Oikawa
    • 1
  • Shunsuke Matsuno
    • 1
  • Takuto Arita
    • 1
  • Naoharu Yagi
    • 1
  • Hiroaki Semba
    • 1
  • Yuko Kato
    • 1
  • Takayuki Otsuka
    • 1
  • Tokuhisa Uejima
    • 1
  • Takeshi Yamashita
    • 1
  1. 1.Department of Cardiovascular MedicineThe Cardiovascular InstituteTokyoJapan

Personalised recommendations